Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Goodwill & Intangibles (2009 - 2025)

Grifols' (GIFLF) quarterly Goodwill & Intangibles came in at $11.1 billion in Q4 2025, up 0.83% on a YoY basis from $11.0 billion in Q4 2024, and up 0.83% quarter-over-quarter from $11.0 billion in Q4 2024.

Analysis

Grifols (GIFLF) Goodwill & Intangibles (2009 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Goodwill & Intangibles for 17 consecutive years, with $11.1 billion the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Goodwill & Intangibles rose 0.83% year-over-year to $11.1 billion; the trailing twelve-month figure through Dec 2025 stood at $11.1 billion (up 0.83% YoY), and the FY2025 full-year result was $10.8 billion, down 2.13% from the prior year.
  • Goodwill & Intangibles advanced to $11.1 billion in Q4 2025 per GIFLF's latest filing, from $11.0 billion in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $11.1 billion in Q4 2025 and bottomed at $21.6 million in Q4 2021.
  • Historically, Goodwill & Intangibles has averaged $4.6 billion across 5 years, with a median of $326.7 million in 2023.
  • The sharpest annual moves came in 2021 and 2024: Goodwill & Intangibles tumbled 90.19% in 2021, then surged 3278.68% in 2024.
  • Over 5 years, Goodwill & Intangibles stood at $21.6 million in 2021, then jumped by 1334.25% to $309.8 million in 2022, then rose by 5.46% to $326.7 million in 2023, then soared by 3278.68% to $11.0 billion in 2024, then advanced by 0.83% to $11.1 billion in 2025.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods registered $11.1 billion, $11.0 billion, and $326.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 11.13 Bn
Dec 31, 2024 11.04 Bn
Dec 31, 2023 326.68 Mn
Dec 31, 2022 309.77 Mn
Dec 31, 2021 21.60 Mn
Dec 31, 2020 220.27 Mn
Sep 30, 2020 8.95 Bn
Mar 31, 2020 8.61 Bn
Dec 31, 2019 8.46 Bn
Sep 30, 2019 8.77 Bn
Mar 31, 2019 8.43 Bn
Dec 31, 2018 7.53 Bn
Sep 30, 2018 7.65 Bn
Jun 30, 2018 7.56 Bn
Mar 31, 2018 7.11 Bn
Dec 31, 2017 6.90 Bn
Jun 30, 2017 6.74 Bn
Dec 31, 2016 5.23 Bn
Sep 30, 2016 5.11 Bn
Jun 30, 2016 5.20 Bn